Anika Therapeutics (ANIK) Change in Acquisitions & Divestments (2015 - 2021)

Anika Therapeutics (ANIK) has reported Change in Acquisitions & Divestments for 7 consecutive years, with $2.5 million the latest figure, recorded in Q1 2021.

• On a quarterly basis, Change in Acquisitions & Divestments fell 83.32% year-over-year to $2.5 million in Q1 2021; TTM through Dec 2021 was $2.5 million, a 94.44% decrease from a year earlier, with the FY2021 full-year figure at $2.5 million, down 94.44% from the prior year.
• Change in Acquisitions & Divestments was $2.5 million for Q1 2021 at Anika Therapeutics, down from $18.0 million in the prior quarter.
• Over five years, Change in Acquisitions & Divestments peaked at $58.8 million in Q4 2019 and troughed at $2.5 million in Q1 2021.
• A 5-year average of $16.6 million and a median of $11.5 million in 2018 frame the typical range for Change in Acquisitions & Divestments.
• Across the five-year window, Change in Acquisitions & Divestments soared 411.06% in 2019 and sank 83.32% in 2021, its largest moves.
• Over 5 years, Change in Acquisitions & Divestments stood at $10.2 million in 2017, then gained by 12.2% to $11.5 million in 2018, then soared by 411.06% to $58.8 million in 2019, then sank by 69.37% to $18.0 million in 2020, then slumped by 86.11% to $2.5 million in 2021.
• The last three Change in Acquisitions & Divestments figures came in at $2.5 million (Q1 2021), $18.0 million (Q4 2020), and $7.0 million (Q3 2020), per Business Quant data.